Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting epigenetic dependencies in ovarian cancer therapy
Aisling Y. Coughlan, Giuseppe Testa
International Journal of Cancer (2021) Vol. 149, Iss. 10, pp. 1732-1743
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 2
Genetically Engineered Artificial Exosome-Constructed Hydrogel for Ovarian Cancer Therapy
Qian Li, Qingxu Song, Zhipeng Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 10376-10392
Closed Access | Times Cited: 36
Co‐Expression of Dominant‐Negative TGF‐β Receptor 2 Enhances the Therapeutic Efficacy of Novel TREM1/DAP12‐BB‐Based CAR‐T Cells in Solid Tumours
Shujia Zhu, Jianping Hu, Jie Lin, et al.
Immunology (2025)
Open Access | Times Cited: 1
Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
Aarushi Audhut, Sofie Deschoemaeker, Lize Allonsius, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4037-4037
Open Access | Times Cited: 20
Regulation of PEST-containing nuclear proteins in cancer cells: implications for cancer biology and therapy
Kuirong Jiang, Yunxia Zhu, Zhi-Liang Jiang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Molecular Management of High-Grade Serous Ovarian Carcinoma
Paula Punzón-Jiménez, Víctor Lago, Santiago Domingo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13777-13777
Open Access | Times Cited: 18
The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
Ieva Vaicekauskaitė, Rasa Sabaliauskaitė, Juozas Rimantas Lazutka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13670-13670
Open Access | Times Cited: 16
Diagnostic value of plasma-derived exosomal miR-223 for epithelial ovarian cancer
Li Yang, Zhihong Yang, Zhihui Liu, et al.
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway
Yixiong Chen, Lufang Wang, Na Chen, et al.
Translational Oncology (2024) Vol. 47, pp. 102052-102052
Open Access | Times Cited: 3
The Role of Iron and Cobalt in Gynecological Diseases
Adrianna Ćwiertnia, Mateusz Kozłowski, Aneta Cymbaluk‐Płoska
Cells (2022) Vol. 12, Iss. 1, pp. 117-117
Open Access | Times Cited: 14
Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study
Dongzhi Hu, Dongdong Ma, Zijian Zhang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells
Ranim El Baba, Sandy Haidar Ahmad, Franck Monnien, et al.
Oncogene (2023) Vol. 42, Iss. 41, pp. 3047-3061
Open Access | Times Cited: 7
The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment
Molly Davies, Matthew G. Davey, Nicola Miller
Genes (2022) Vol. 13, Iss. 11, pp. 2054-2054
Open Access | Times Cited: 12
Spotlight on New Hallmarks of Drug-Resistance towards Personalized Care for Epithelial Ovarian Cancer
Simona Frezzini, Sara Lonardi
Cells (2024) Vol. 13, Iss. 7, pp. 611-611
Open Access | Times Cited: 2
Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning
Soukaina Amniouel, Keertana Yalamanchili, Sreenidhi Sankararaman, et al.
BioMedInformatics (2024) Vol. 4, Iss. 2, pp. 1396-1424
Open Access | Times Cited: 2
Detection of dual-methylated BRCA1/BRCA2 cell-free DNA for ovarian cancer on an aptamer-based integrated microfluidic system
Chih‐Hung Wang, Yang-Sheng Shao, Keng‐Fu Hsu, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153478-153478
Closed Access | Times Cited: 2
Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer
Rong Zhang, Lei Li, Huihui Li, et al.
Journal of Ginseng Research (2023) Vol. 48, Iss. 1, pp. 40-51
Open Access | Times Cited: 6
BRD9 Bifunctional Degraders for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 12, pp. 1879-1880
Open Access | Times Cited: 13
Association of pre-diagnosis specific color groups of fruit and vegetable intake with ovarian cancer survival: results from the ovarian cancer follow-up study (OOPS)
Yuyang Liu, Ting‐Ting Gong, Yi-Zi Li, et al.
Food & Function (2023) Vol. 14, Iss. 18, pp. 8442-8452
Closed Access | Times Cited: 5
Exploration of organoids in ovarian cancer: From basic research to clinical translation
Siyu Li, Ningjing Lei, Mengyu Chen, et al.
Translational Oncology (2024) Vol. 50, pp. 102130-102130
Open Access | Times Cited: 1
The Prognosis and Immunotherapy Prediction Model of Ovarian Serous Cystadenocarcinoma Patient was Constructed Based on Cuproptosis-Related LncRNA
Junliang Guo, Muchuan Zhou, Jinhong Li, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 262, Iss. 2, pp. 63-74
Open Access | Times Cited: 2
Survival prognosis model for elderly women with epithelial ovarian cancer based on the SEER database
Yingping Zhou, Aifen Wang, Xin Sun, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Novel Compounds for Targeted Degradation of BRD9 and Their Use for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 13, Iss. 1, pp. 17-18
Open Access | Times Cited: 5
Bifunctional Compounds as SMARCA2 Degraders for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 13, Iss. 1, pp. 15-16
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top